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. Increasing knowledge about the biology of the genome, however, has led to recognition of the likely role of epigenetic variation in human health and disease 2 . This has spawned a new field of investigation -epigenetic epidemiology
-which combines emerging epigenomic technologies with established epidemiological approaches 3 . Large cohorts of individuals are being intensively studied to assess the extent to which epigenetic marks vary among individuals and throughout lifetimes as a result of environmental exposures and life experiences. In addition, epigenomewide association studies (EWASs), which primarily aim to identify DNA methylation differences associated with disease predisposition or progression, are now underway for many complex disease phenotypes 4 , and epigenomic information is currently being assessed as a means to improve clinical diagnosis and disease subtyping 5 . Just as the immediate post-genomic era was characterized by considerable enthusiasm about the potential of genetic epidemiology, much excitement surrounds the promises of studying the epigenetic contribution to diseases in human populations. Sensational headlines adorn both the scientific and the lay media with increasing frequency (BOX 2) . However, this is very much a nascent arena of investigation in which the publication of empirical data is only starting to gain momentum, and caution is needed. become a mature discipline. Here, primarily for researchers moving into the field of epigenetics, we outline some of the promises afforded by population-based epigenomic approaches, before highlighting some key differences between genetic epidemiology and such epigenomic studies and discussing the issues that are pertinent to the successful planning and interpretation of studies in this emerging field.
Linking epigenetics and disease
Epigenetic dysfunction is a known hallmark of several rare developmental syndromes 6 and cancer 7 , but its role in common nonmalignant disease phenotypes is fairly unexplored. Many epigenetic marks are malleable, responding to factors in both the external and internal milieu, thus providing a mechanism for the interaction of the genome with environmental exposures, which is a key pathway to disease pathogenesis. Indeed, various disease-associated nutritional, chemical, physical and psychosocial factors have been correlated with changes to the epigenome, particularly at the level of DNA methylation 8 . For example, some of the most convincing environmentally associated epigenetic differences are reported for tobacco smoke: consistent differentially methylated loci have been observed in studies of in utero 9 and adulthood 10, 11 exposure. That said, not all epigenetic variation is environmentally driven, and some appears to be random in nature. It has been shown, for example, that specific regions of the genome are characterized by stochastically variable DNA methylation 12 , particularly in the vicinity of genes that are involved in development and morphogenesis 13 . Recent work also demonstrates that epigenetic processes underlie the stochastic choice of allelic expression in human neural stem cells 14 , providing clonal diversity to developing tissues, such as the human brain. The observation that both deterministic and stochastic factors can shape epigenomic variation matches many of the hallmarks of complex disease in human populations 15 . After they have been established, such environmentally or stochastically induced changes can be stably propagated through mitosis, potentially explaining how many Abstract | The epigenome has been heralded as a key 'missing piece' of the aetiological puzzle for complex phenotypes across the biomedical sciences. The standard research approaches developed for genetic epidemiology, however, are not necessarily appropriate for epigenetic studies of common disease. Here, we discuss the optimal execution of population-based studies of epigenetic variation, which will contribute to the emerging field of 'epigenetic epidemiology' and emphasize the importance of establishing a causal role in pathology for disease-associated epigenetic changes. We propose that improved understanding of the molecular mechanisms underlying human health and disease are best achieved through carrying out studies of epigenetics in populations as a part of an integrated functional genomics strategy.
Dissecting the epigenetic architecture of common disease could substantially increase our understanding of aetiology, but the practicalities of undertaking this research are not trivial. Good study design is vital, and it is important to be aware of the limitations associated with current approaches
. To minimize disappointment and to maximize the benefits from ongoing efforts, epigenetic epidemiology must quickly
The current state of play in epigenetic populationbased studies is reminiscent of the early days of complex disease genetics common human diseases have substantial developmental origins 16 . Indeed, the epigenome appears to be particularly malleable during embryogenesis, and epigenetic changes occurring at this time may have roles in disease susceptibility after birth 17 . Studies are starting to make progress in describing how such epigenetic changes occurring early in development are linked to health and disease later in life. It has been shown, for example, that the epigenetic signatures of prenatal famine are apparent in peripheral blood cells many decades after exposure 18 , and obesity-associated hypermethylation at a CpG island in the proopiomelanocortin (POMC) gene appears to become manifest early in development and then remains stable across tissues and through the life course 19 . Epigenetic variation also explains many of the other frequent features of common complex disease, most notably phenotypic discordance within monozygotic (MZ) twin pairs. Although MZ twins are more similar for most common diseases than dizygotic (DZ) twins -highlighting a clear heritable component to susceptibility -the overall level of concordance is generally substantially <100%. Because MZ twins share an identical DNA sequence, disease-discordant MZ twin pairs provide an ideal model for examining the contribution of environmentally driven epigenetic factors in disease 20 . In addition, epigenetic processes are believed to contribute to the frequent gender differences in prevalence observed for many common diseases 21 , parental origin effects in genetic studies 22 , and the windows of heightened environmental sensitivity during certain periods of development described above 18 . Although the broad aim is to relate inter-and intra-individual variation in the epigenome to health and disease phenotypes in the general population, many studies focus on more specific questions, such as the identification of disease-associated epigenetic variation or understanding how health-related environmental exposures influence epigenetic processes across the lifespan. Other areas of research are more basic, such as using longitudinally sampled cohorts to assess the extent to which regions of the genome are epigenetically stable or plastic in the context of ageing. Epigenetic approaches are also used to explore general features of diseases (rather than specific disease phenotypes), such as sex differences, MZ twin discordance and the role of stochastic factors in pathogenesis.
Specific concerns for epigenetic studies
The current state of play in epigenetic population-based studies is reminiscent of the early days of complex disease genetics when candidate gene association studies were underpowered, focused on single genetic variants without knowledge about their context or functionality and often yielded contradictory outcomes. Compared with genetic studies, however, similar studies of epigenetics are constrained by several additional biological and methodological design issues; it would be naive to assume that we can simply undertake EWAS analyses on samples that have been previously used in GWASs. Our basic knowledge about the epigenome is still fairly limited, and it is difficult to make assumptions about the nature and location of disease-relevant variation
. Furthermore, epigenetic marks are by definition tissue-specific, which has obvious implications for their analysis
. At this early stage, therefore, the field must work towards implementing a research framework that uses study design and methodological approaches that are optimal for yielding statistically robust and biologically relevant findings 23 . In particular, because germline genetic variation is a static entity, in GWASs, researchers are largely able to replace conventions in the design of studies with respect to selection biases, confounding and appropriateness of controls by the simple rule that 'bigger is better' . Such genetic studies, therefore, can focus on comparisons of the groups that can be recruited most efficiently: namely, retrospectively enrolled cases and independently collected (convenience) control groups 24 . This is not a viable approach for equivalent epigenetic analyses; the dynamic properties of the epigenome mean that we must return to the conventional rules that govern the design of observational studies. For example, if control groups are not carefully chosen to represent the same study base as cases, confounding will lead to spurious epigenetic associations. Statistical correction for the obvious factors that often differ between cases and controls and are known to influence the methylome -including age 25 , gender 21 , smoking 9, 10 and cellular heterogeneity 26 -can to some extent alleviate this problem, but unmeasured environmental exposures and demographic factors will almost certainly introduce residual confounding that cannot be remedied. Similar problems can result from batch effects introduced by technical variation: for example, different DNA extraction protocols and lack of randomization during data generation 27 . Furthermore, the disease process itself or treatments may cause epigenetic changes, meaning that the associations identified in epidemiological studies could represent a secondary effect of pathogenesis 28 or the medication 29 used to treat it. Detecting DNA sequence variation is fairly straightforward; high-throughput microarray and sequencing-based approaches are reliable and economical, and there are well-established analytical pipelines adopted across the research community that facilitate collaboration and meta-analysis. Interrogating the methylome is more of a challenge, especially at the scale and sensitivity needed for large studies of complex phenotypes and exposures. Although various high-throughput techniques are now available to quantify genome-wide patterns of DNA methylation systematically, each platform differs with regard to enrichment strategy, CpG coverage, quantification accuracy and analytical approach 30 . At one extreme is whole-genome bisulphite sequencing, which can, in principle, interrogate all ~28 million CpG sites across the human genome. Although this is currently considered the 'gold standard' for methylomic profiling, the sequencing and analytical requirements needed to quantify subtle inter-individual differences in DNA methylation reliably across large sample cohorts render it impractical for large-scale studies. On the other extreme is the Illumina
Box 1 | Defining epigenetic epidemiology
Although discussion of 'epigenetic epidemiology' is becoming increasingly common, and the term is now in widespread use, there are important nuances in how this field of investigation is actually defined. Here, we define epigenetic epidemiology as the integration of epigenetic analyses into population-based epidemiological research with the goal of identifying both the causes (that is, environmental, genetic or stochastic) and phenotypic consequences (that is, health and disease) of epigenomic variation. Other definitions are narrower and have a more direct focus on environmental epigenetics and the specific analysis of transgenerational epigenetic effects 72 or the developmental origins of health and disease 73 . As a fairly immature discipline, epigenetic epidemiology has a lot to learn from the much broader field of classical epidemiology, especially with regard to causal inference and establishing the validity of epigenetic associations. 31 , which is now being widely adopted by the research community. Although the cost, throughput and quantitative accuracy make this a highly suitable platform for large-scale studies, the array targets <2% of the CpG sites present in the human genome and remains predominantly focused on sites in promoters and CpG islands that may not be the most relevant for studies of phenotypic variation. Thus technological, financial and analytical constraints mean that few, if any, of the current swathe of EWAS analyses underway at present can be considered truly 'epigenome-wide' .
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Cohort and sample considerations
Despite the limitations discussed above, several strategies can be used to maximize our ability to make causal inference in epigenetic analyses. The most robust findings may result from analyses carried out within prospective cohort studies that allow the assessment of epigenetic changes over time and the ability to see how these patterns relate to temporal changes in exposure and disease prevalence 32 Given increasing evidence that some exposureinduced epigenetic changes are rapid and temporary 10, 33 , focused analyses of samples taken immediately before and after exposure may be important to distinguish acute effects from the more persistent long-term epigenetic alterations seen for other types of exposure 18 . Of course, these approaches are not always practical in human populations because the timing of many exposures is not known in advance, and therefore many acute effects may be best explored using targeted experimental approaches.
The analysis of disease-discordant MZ twins is another powerful design that is used in epigenetic epidemiology. For example, an optimal study design that addresses the contribution to disease risk of epigenetic variation induced during postnatal development or ageing would involve the longitudinal assessment of epigenetic changes in a cohort sample of MZ twins, sequentially examining within-pair epigenomic differences as they become discordant for exposure and/ or disease (FIG. 2) . To study the impact of the environment on the epigenome during the crucial intra-uterine period, birth cohorts following individuals from periconception into adulthood will be most valuable 34 . Of particular value in this respect, despite their moderate sample sizes, are unique experimental and quasi-experimental settings that circumvent some of the issues common to observational studies, including trials on periconceptional micronutrient supplementation 35 An overarching problem is that most ongoing population studies were not designed with epigenetic research in mind, and no single study can incorporate all of the elements that are required to demonstrate unequivocally the validity of an epigenetic association. For example, few studies can combine deep phenotyping, follow-up periods covering multiple phases of life, frequent longitudinal biobanking of both peripheral and target tissues and detailed data on (and sufficient contrasts in) relevant environmental exposures with the sufficient numbers of incident disease cases that are required for an optimal epigenetic analysis. Therefore, the combined analysis of multiple studies with complementary strengths will be necessary to identify meaningful and interpretable epigenetic associations.
Analytical considerations
In population-based genetic studies, the production and analysis of data are fairly straightforward, but equivalent pipelines for processing large-scale epigenomic data are still being developed. Optimal strategies should aim to incorporate the analysis of confounding variables and longitudinal data, the ultimate goal being to assess causality and to determine the biological relevance of disease-associated epigenetic variation.
Analysis strategies.
Consensus has yet to be reached regarding the optimal analytical approach for identifying differential DNA methylation in data from human cohorts. Recent EWAS analyses of exposures such as smoking, for example, have adopted a GWAS-like approach: that is, they have independently assessed DNA methylation at individual CpGs to identify discrete differentially methylated positions (DMPs) 10, 11 . Although straightforward, more advanced analysis strategies that focus on the identification of differentially methylated
Box 2 | Epigenetics in the media
There is considerable interest in epigenetic research in the press (see the figure for examples), but many of the recent front-page headlines make unsubstantiated claims that are not necessarily supported by current empirical research. Most of the speculation involves pitting epigenetics against traditional genetic approaches to phenotypic variation and neo-Lamarckism against Darwinian evolution. In reality, there is no such dichotomy; epigenetic processes must operate within the context of a genomic sequence, and there is considerable interaction between genetic variation and the epigenome. Furthermore, the notion of transgenerational epigenetic inheritance remains highly controversial and is likely to be of negligible effect over evolutionary timescales. Epigenetics must be careful to avoid some of the hype that surrounded the early days of genetic epidemiology, and it is important for the community to manage expectations. Nature Reviews | Genetics regions (DMRs) are likely to be more productive 36 . Such a strategy is based on the premise that the proportion of methylated cytosines across a region, rather than a methylated cytosine at any specific position, controls chromatin conformation and thus the transcriptional potential of a gene 37 . This model is supported by the observation that differential DNA methylation in malignant cells 7 , between tissue and cell types 38 , across the inactive X chromosome in females 37 and in response to prenatal environmental exposure 39 is not restricted to specific CpG sites but often extends across genomic regions. Statistical methodology should be developed to use the patterns in DNA methylation data, as exemplified by correlations between sets of nearby CpGs 40 , and to use available genome annotations 36 to bring together groups of CpGs of similar function in order to identify DMRs. Such an approach potentially reduces the risk of false-positive findings resulting from technical artefacts that are more likely to affect single CpGs, affords more power by minimizing multiple testing issues and guides the biological interpretation of results 41 . A recent study highlights the utility of this strategy by detecting genomic regions of variable DNA methylation associated with gestational age at birth 42 . However, the analysis of data produced using technologies with a sparse coverage of many genomic regions, such as the Illumina 450k array, will often be able only to identify DMPs. Furthermore, the DMR approach could miss effects mediated by functional variation occurring at single 'critical' CpG sites. This could be important in situations in which the methylation of specific cytosines in transcription factor binding sites is responsible for reducing binding affinity and thus transcription, as exemplified by effects on CTCF binding 43 .
Increased awareness about the importance of stochastic epigenetic drift in development and age-related common diseases 13 suggests that analysis strategies should also evaluate changes in the variability of the epigenome at a given locus rather than simply searching for disease-or exposureassociated DMRs 40 . In addition to testing specific genomic regions independently, the analysis of functionally related gene sets is likely to be informative, especially given the hypothesized role of epigenetic processes in 'fine-tuning' key biological processes such as the coordinated adaptive changes occurring in response to an adverse prenatal environment 44 . In further support of such an approach, recent studies highlight how the methylome is organized into modules of co-methylated features, and functional networks are associated with cellular phenotype 38 and ageing 45 , for example. Finally, Mendelian randomization may be a useful strategy to maximize causal inference in epigenetic epidemiology 28 , although the utility of this approach still awaits empirical confirmation. A first step will be the generation of comprehensive maps of methylation quantitative trait loci (meQTLs) across the genome; of particular interest will be those meQTLs that affect DNA methylation across tissues, as they might help to predict DNA methylation in normally inaccessible organs that are directly involved in disease pathogenesis.
Replication.
A major factor driving success in GWASs is the use of replication strategies; similar approaches should also become
Box 3 | Epigenetic measurements across the genome and among tissues
What should we study? Contemporary studies of epigenetic variation in human populations focus almost entirely on DNA methylation primarily because, unlike chromatin and RNA, it can be routinely studied using standardized methods to analyse existing genomic DNA sample archives. In reality, the epigenome is much more complex: there is a suite of additional interacting epigenetic processes (including histone protein modifications and non-coding RNAs 74 ) that have important functional consequences. In large studies on human cohorts, the potential to measure these is generally lost during routine sample collection, and biological sampling strategies should be developed for longitudinal population-based cohorts that can also preserve material suitable for the analysis of inter-individual variation in these layers of the epigenome.
Furthermore, DNA methylation is not the only epigenetic modification to DNA; novel DNA modifications (such as 5-hydroxymethylcytosine (5hmC) and 5-formylcytosine (5fC)) with unknown functional consequences are being identified 75, 76 . Importantly, many current methods for analysing DNA methylation do not detect or distinguish these modifications; this has obvious implications for the interpretation of existing methylomic data. For example, methods based primarily on the treatment of genomic DNA with sodium bisulphite cannot distinguish DNA methylation from hydroxymethylation 77 .
Where should we look in the genome? Initial studies of epigenetic variation in human populations mainly focused on specific genomic regions, typically discrete CpG islands located in promoters upstream of a priori candidate genes. These conserved CG-rich regions, which are associated with ~40% of human genes, are known to be involved in the regulation of developmentally expressed housekeeping genes and have an important role in the pathogenesis of cancer. Recent work, however, highlights the importance of DNA methylation outside promoter CpG islands, indicating that functionally relevant epigenomic variation primarily occurs at non-promoter CpG islands, low CG-content promoters, enhancers and intronic sequences 2, 38 .
What tissues should be studied?
A major challenge that distinguishes epigenetic and genetic studies is the choice of tissue type, which is largely irrelevant for genetic studies of germline genetic variation. Specifically, there is often limited availability of the primary disease-or exposure-relevant target tissue (or cell type). Existing biobanks that track large numbers of longitudinally assessed and deeply phenotyped individuals have generally archived DNA only from peripheral sources (for example, whole blood). By contrast, biobanks of internal tissues obtained during surgery or autopsy are frequently limited to small numbers of highly selected and poorly phenotyped individuals, and there is limited access to equivalent tissues from representative controls.
It will be vital for the current reference epigenome mapping projects to explore the extent to which easily accessible cells obtained from tissues such as whole blood, buccal or stool (reflecting the mesodermic, ectodermic and endodermic germ cell layers, respectively) can be used to address questions about inter-individual epigenomic variation in inaccessible tissues such as the heart, brain, pancreas or lung. A recent intra-individual cross-tissue study concluded that, as expected, intra-individual between-tissue variation in DNA methylation greatly exceeds inter-individual differences for any one tissue but suggested that some inter-individual variation may be correlated between blood and other tissues 38 . Further cross-tissue comparisons of DNA methylation and other epigenetic marks within the same individual should be a priority area for research to create an inventory of epigenetic marks at specific genomic regions for which measurements in blood are informative for one or more internal tissues. These comparisons need to differentiate intra-individual inter-tissue correlations related to true epigenetic variants from cross-tissue similarities caused by genetic variants that influence DNA methylation. Cross-tissue concordance may be higher for epigenetic changes induced in early development that become propagated soma-wide 78 and may become lower in old age owing to tissue-specific epigenetic drift 79 ; therefore, cross-tissue comparison studies should be undertaken across the life course.
routine in the context of epigenetic studies to eradicate false-positive findings resulting from study biases, chance findings and methodological issues. Of course, the routine use of many different DNA methylation profiling methods means that the comparison and meta-analysis of data across studies is not necessarily straightforward. Replication will be greatly facilitated if, as in GWASs, consortia are established in which the same technology platform is used across studies, and standardized data pre-processing and analysis approaches are adopted. Despite its limitations, the Illumina 450K methylation array is currently the most suitable tool to fulfil this role. Importantly, until standard epigenomics methodologies are able to measure DNA methylation precisely at base-pair resolution without any experimental bias, technical validation with an independent method should be used to confirm DMRs (and, even more so, DMPs) associated with disease or exposure.
Interpretation. Although well-designed studies can identify epigenetic associations that are strongly suggestive of being causal and although they can even provide clues about underlying mechanisms if existing genomic annotation data are integrated into the analysis, the conclusions are still based on correlative analyses. Definite evidence relies on other experimental approaches. For example, identified DMRs could act as a proxy for other DNA methylation patterns in cis, could mark the local histone state that is the actual causative agent or could be a relic of past transcription factor binding 2 . Many of the DNA methylation differences currently identified as being associated with disease or environmental exposures are characterized by small absolute changes, often in the range of 5%. Although the functional consequences of such subtle changes are not yet understood, they may represent much larger changes in specific subsets of cells. It is worth being cautious about the interpretation of these small changes, however, especially given the noise that is inherent in many of the platforms that are routinely used for quantifying DNA methylation and the sample sizes that would be required to detect them adequately. An association of DNA methylation with transcriptional activity is generally regarded as an important marker of functional relevance. It is becoming increasingly clear, however, that the relationship between epigenetic variation and gene expression is not straightforward. Certainly, increased DNA methylation is not always associated with gene silencing: gene body hypermethylation, for example, is often associated with active transcription 46 . In addition to regulating the abundance of mRNA transcripts, DNA methylation has been shown to control the production of alternative transcripts 47, 48 and to influence the transcription of distal genes 49 , both of which are difficult to detect using standard approaches. Moreover, the effect of epigenetic variation on transcriptional activity may be highly tissue-specific or may occur during a discrete developmental phase. In vitro reporter gene assays can be used to provide an initial indication about the functional effects of differential DNA
Box 4 | Examples of population-based epigenetic study designs
Many study designs are informative for epigenetic epidemiology. Some examples of study designs for analysing epigenetic variation in human populations are summarized below (see also examples in FIGS 1, 2) . Although published empirical research using these approaches is still limited, several epigenomic studies are currently underway.
Natural experiments
Natural experiments comprise studies in which exposure to a condition of interest is not under direct experimental control; they are the only viable method for examining epigenetic changes following exposure to severe environmental conditions in human populations. The Dutch Hunger Winter Families Study, for example, follows individuals who were in utero during the Dutch famine of 1944 (REF. 80 ), enabling researchers to study how maternal undernutrition across specific gestational time windows affects the subsequent life course and biology of offspring experiencing prenatal famine. Recent epigenetic work on this cohort has highlighted sex-and timing-specific effects of prenatal famine on DNA methylation, especially in regulatory regions associated with imprinted genes such as insulin-like growth factor 2 (IGF2) 18, 81, 82 .
Longitudinal birth cohorts
Longitudinal birth cohorts allow the analysis of epigenetic changes over time and provide the ability to relate these to specific environmental exposures and the development of disease. Some large epigenetic analyses are being carried out within the context of the Avon Longitudinal Study of Parents and Children (ALSPAC) [83] [84] [85] . ALSPAC enrolled ~14,000 pregnant women from the south west of England in 1991 and 1992, and has longitudinally assessed the health and development of their children since birth. For example, the Accessible Resource for Integrated Epigenomics Studies (ARIES) is generating epigenomic information on a range of human tissues at multiple time points across the life course on samples from ALSPAC.
Longitudinal twin studies
Monozygotic (MZ) twins share their genetic sequence, parents, birth date and sex, which means that studies of these twins can be powerful for understanding epigenetic variation. Recent studies have uncovered considerable epigenetic variation between MZ twins across the lifespan 34, 40, 86 , with emerging evidence for increased discordance with age. Disease-associated epigenetic variation has been identified in MZ twins discordant for a range of disorders, including psychosis 55 , autism 87 , breast cancer 88 , systemic lupus erythematosus 89 , Alzheimer's disease 90 and type 1 diabetes 91 . Despite the strengths of the cross-sectional discordant twin approach, it remains difficult to establish cause and effect fully, and a more powerful approach involves the longitudinal analysis of MZ twins as they become discordant for exposure or phenotype 86 (FIG. 2) . The ultimate study would follow MZ twins from periconception, although few resources are available to undertake this research. The Peri/Postnatal Epigenetic Twins Study (PETS) 92 has systematically attempted to explore epigenetic variation between twins at birth. It has reported considerable within-twin differences in DNA methylation that are largely attributable to the combined effects of non-shared intrauterine environmental influences and stochastic factors 34 .
Prenatal cohorts
The prenatal developmental period is believed to be a crucial window for epigenetic malleability. By tracking individuals from the point of conception onwards, researchers can examine how maternal and intrauterine influences interact with the genotype and postnatal environment of the offspring to regulate health and disease. For example, the Southampton Women's Survey (SWS) in the United Kingdom aims to measure the pre-pregnant characteristics of women aged 20-34 years, recruiting 12,500 women who are being followed through their subsequent pregnancies 93, 94 . All aspects of pregnancy are being assessed to study maternal influences that initiate developmental adaptations and mediate long-term consequences for the health of the offspring.
In vitro fertilization conception cohorts
Assisted reproductive technologies (ART), such as in vitro fertilization (IVF) have been linked to epigenetic disruption in the developing embryo, especially at imprinted loci, and studies such as the Danish National IVF Cohort Study 95 are particularly valuable for understanding the epigenetic mechanisms involved in imprinting disorders 96 . methylation identified in EWAS analyses 50 , although they may not reflect the situation in vivo and cannot assess the effects of small changes in DNA methylation. Experimental tools that can be used in conjunction with the approaches discussed here to begin to establish indications of causality include assays based on different types of human stem cells to model development and differentiation 51 , and the verification of human findings in animal models for DMRs with conserved function in which confounding variables can be largely controlled for and specific tissues can be easily isolated 52 .
Into the future It will soon be realistic to assess methylomic variation at base-pair resolution across thousands of samples, which will greatly advance studies in the field of epigenetic epidemiology. Given the considerable interest in this area of research, it is vital that expectations are carefully managed, particularly given the challenges that are involved in executing a high-quality epigenetic study and in establishing causality. Moving forwards, it will be important to broaden our horizons beyond DNA methylation and to develop analytical strategies that maximize our chances of determining cause and effect in longitudinally sampled cohorts. Importantly, we also have a lot to learn about the basic biology of epigenetic gene regulation and other pertinent issues, such as the extent of transgenerational epigenetic inheritance.
Cataloguing inter-individual epigenetically variable regions of the genome. Projects such as ENCODE 2 , the US National Institutes of Health (NIH) Epigenomics Roadmap 53 and the International Human Epigenome Consortium 54 are generating cell-specific reference data sets that provide a basis for delineating the complex interplay between epigenomic processes and the transcriptome. However, progress in understanding the influence of epigenetics in disease will also require the identification of genomic regions harbouring inter-individual variation in DNA methylation: that is, the epigenetic equivalent of single-nucleotide polymorphism (SNP) databases. Systematic EWASs should ultimately interrogate genomic regions in which DNA methylation is both biologically relevant and variable between individuals: for example, using customized arrays or targeted enrichment before highly parallel bisulphite sequencing.
Overcoming issues of tissue-specificity.
Although there is hope that existing biobanks, which are largely comprised of easily obtained peripheral tissues, might be used successfully to identify epigenetic biomarkers of disease-associated changes occurring in inaccessible tissues
, efforts to add longitudinal biopsies (from potentially disease-relevant tissues such as subcutaneous fat and muscle) and postmortem material to those biobanks would be very useful. Certainly, disease-associated epigenetic differences identified in whole blood should be subsequently tested in disease-relevant tissues from patients and controls 55 . If such clinical samples are not available, the correlation for that epigenetic mark between blood and the diseaserelevant tissue should be established 19 . Furthermore, because most tissues consist of multiple epigenetically distinct cell types, a concern is that when the cellular content of a given tissue is directly associated with the actual disease outcome being studied -for example, in inflammatory or neurodegenerative disorders -apparent diseaseassociated epigenetic differences may simply reflect differences in cellular composition. For whole blood, rountine cell counts 23 or algorithms to infer cellular composition from epigenomics data 26 can be applied to control for this variation statistically, and similar approaches are being developed for other heterogeneous tissues, such as the brain 56 . These approaches may not always be sufficient -for example, in diseases with a strong inflammatory component 57 -and it may be preferable to isolate specific cell types via laser capture microdissection or cell sorting. Such approaches will also improve power to detect disease-associated changes that are manifest in only a small subset of cells, which may not be detectable in analyses of whole tissue. , presumably affecting gametogenesis, and may be studied in family studies. The epigenetic changes stemming from prenatal environment and their association with disease phenotypes early in life may be investigated using in vitro fertilization (IVF) cohorts, archived Guthrie cards 98 , and birth cohorts tracking life from as early as periconception. Quasi-experimental settings, such as historical famines, are among the few opportunities to link the early-life environment to health decades later when many of the common diseases actually start to develop. Prospective cohort studies (especially involving twins) that longitudinally sample peripheral tissues and take biopsies from disease-relevant tissues are likely to be particularly crucial for understanding the contribution of age-related epigenetic changes in common disease pathogenesis. Finally, short-term interventions might identify specific exposures that induce tissue-specific epigenetic modifications, and long-lived families may assist in identifying the importance of maintaining epigenetic control for healthy ageing. Using such study designs in combination could facilitate analysis of epigenetic variation across human lifetimes, in different tissues and in response to various exposures. d, days; m, months; w, weeks; y, years. Nature Reviews | Genetics The longitudinal analysis of epigenetic changes in a population cohort of monozygotic (MZ) twins is a strategy that can be particularly informative for understanding epigenetic variation and its links to disease. MZ twins share their DNA sequence, parents, birth date and sex, and are likely to have experienced a very similar prenatal environment. The figure highlights tissue-specific epigenetic marks (green) being established during gestation, which are stably maintained through life in both twins. Some stochastic epigenetic drift (orange) occurs during development, resulting in some epigenetic discordance between the two twins, but this is not necessarily related to the phenotype of interest. Non-shared environmental risk factors (lightning symbol) can induce exposure-specific alterations (red), which may be present across cell types but induce pathogenic changes only in tissues in which the disease-associated gene (blue bar) is expressed. The longitudinal sampling from these twins would highlight high phenotypic and epigenetic concordance at time A, with some stochastic epigenetic drift. After exposure (time B), the twins might become discordant for disease and show epigenetic differences at the diseaseassociated locus. Further sampling at time C might identify changes caused by the disease itself or perhaps a tissue-specific effect of medication. Tissuespecific mark
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Establishing the importance of transgenerational epigenetic inheritance. There is increasing speculation about the importance of non-genetic transgenerational inheritance 58, 59 , which, if it occurs, could have important implications for our understanding of the causes of individual differences 60 . Although there is some evidence that certain environmental exposures can precipitate phenotypic changes across multiple generations 61, 62 , it is not certain that these effects are mediated by meiotically inherited epigenetic variation surviving the erasure of epigenetic marks in the germ line and early in pre-implantation mammalian development 63 . They may instead result from changes induced by parental behaviour -for example, it has been observed that maternal behaviour in rats induces epigenetic changes in their offspring 64 -or may be a consequence of multigenerational exposure. Although several examples of the meiotic stability of epigenetic marks have been reported in non-human mammals 65 , and although recent data suggest that certain regions of the genome appear to escape complete reprogramming partially during primordial germ cell formation and after fertilization in mammals 66, 67 , convincing empirical evidence that this phenomenon is widespread in humans and is yet to be reported, and its wider importance within the context of disease and over the time course of evolution is unclear 68 .
Towards an integrated approach. Rather than investigating epigenetic factors in isolation, it is clear that an integrative functional omics paradigm will be optimal for understanding the aetiological pathways to common disease and tracing molecular changes through layers of biological information to disease outcomes. For example, the integration of epigenomic and transcriptomic data will greatly enhance the interpretation of EWAS analyses as, despite the caveats discussed above, differential gene expression, including from alternative transcripts 47, 48 and longrange effects 49 , remain the primary readouts of functionality. Because DNA sequence variation can directly influence DNA methylation in cis 69 and because evidence already supports an enrichment of meQTLs among GWAS-nominated loci for several disorders 70 , it is likely that the interpretation of genetic data can be improved by integrating allele-specific epigenetic information into analyses 71 . Conversely, some epigenetic marks (for example, genomic imprinting and stochastically mediated allelic skewing 71 ) may contribute to the 'missing heritability' of complex disease by masking direct associations between genotype and phenotype or may mediate gene-environment interactions at a molecular level.
Conclusion
There is hope that understanding the epigenetic basis of common disease will yield vital insights about their aetiology and will eventually provide novel ways to improve health. Despite the challenges described in this article, many of the factors relevant for the optimal execution of populationbased epigenetic research are understood. Maximum information will be obtained from studies integrating epigenetic variation with other types of multi-dimensional omics data. Such an approach, if successful, will ultimately provide more powerful classifiers of disease risk than those based on DNA sequence variation alone.
Glossary
Chromatin
The combination of DNA, RNA and protein that constitute the chromosomes in eukaryotic cells. Broadly, heterochromatin is associated with transcriptional repression and euchromatin is associated with transcriptional activity.
DNA methylation
The covalent binding of a methyl group at position 5 of the cytosine pyrimidine ring in CG dinucleotides often associated with the repression of transcription when present at promoters and enhancers.
Epigenetic
Describes mitotically heritable, but reversible, changes in gene expression mediated primarily by modifications to DNA and chromatin structure.
Epigenome
The entirety of epigenetic information in a cell, including DNA methylation, histone modifications, histone variants and non-coding RNAs.
Epigenome-wide association studies (EWASs) . Systematic assessments of a specific epigenetic mark, usually DNA methylation, across the genome in groups of individuals that are different for a given environmental exposure, trait or disease with the goal of identifying differences associated with that exposure or phenotype.
Histone
Histone proteins package DNA into structural units called nucleosomes. Covalent post-translational histone modifications include acetylation, methylation, phosphorylation, sumoylation and ubiquitylation; these can influence gene expression through changes in chromatin structure.
Mendelian randomization
An approach that uses a genetic proxy for DNA methylation (that is, methylation quantitative trait loci (meQTLs)) to identify a causal relationship between exposure and epigenetic variation, assuming that genetic associations are largely immune to residual confounding and reverse causation. Although such an approach requires that DNA methylation at relevant loci is influenced by both the environment and genetic variation, some examples of such a scenario have been reported.
Methylation quantitative trait loci
(meQTLs). Genetic variants that influence DNA methylation in cis via allele-specific DNA methylation or in trans: for example, by affecting the gene function of a DNA methylation modifier.
Methylome
The entirety of DNA methylation marks across the genome.
